Questions raised by the Benelux CML study group: Results from the randomized study with hydroxyurea alone versus hydroxyurea combined with low- dose interferon-α 2b for chronic myeloid leukemia [10] (multiple letters)

H. M. Kantarjian, M. Talpaz, J. C. Kluin-Nelemans, A. Delannoy, A. Louwagie

Research output: Contribution to journalLetterpeer-review

4 Scopus citations
Original languageEnglish (US)
Pages (from-to)2984-2987
Number of pages4
JournalBlood
Volume92
Issue number8
DOIs
StatePublished - Oct 15 1998

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this